Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CLVT 
CLARIVATE PLC (CLVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/08/2025: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $5.14
1 Year Target Price $5.14
| 3 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -58.01% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/08/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.59B USD | Price to earnings Ratio - | 1Y Target Price 5.14 |
Price to earnings Ratio - | 1Y Target Price 5.14 | ||
Volume (30-day avg) 10 | Beta 1.4 | 52 Weeks Range 3.04 - 7.15 | Updated Date 08/9/2025 |
52 Weeks Range 3.04 - 7.15 | Updated Date 08/9/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.62 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When - | Estimate 0.17 | Actual -0.11 |
Profitability
Profit Margin -17.33% | Operating Margin (TTM) 9.17% |
Management Effectiveness
Return on Assets (TTM) 1.16% | Return on Equity (TTM) -8.18% |
Valuation
Trailing PE - | Forward PE 5.85 | Enterprise Value 6829165587 | Price to Sales(TTM) 1.04 |
Enterprise Value 6829165587 | Price to Sales(TTM) 1.04 | ||
Enterprise Value to Revenue 2.73 | Enterprise Value to EBITDA 9.97 | Shares Outstanding 672219008 | Shares Floating 398444406 |
Shares Outstanding 672219008 | Shares Floating 398444406 | ||
Percent Insiders 16.72 | Percent Institutions 93.01 |
Upturn AI SWOT
CLARIVATE PLC
Company Overview
History and Background
Clarivate was formed in 2016 after being spun off from Thomson Reuters' Intellectual Property & Science business. It provides data and analytics to accelerate the pace of innovation.
Core Business Areas
- Science: Provides information and workflow solutions for scientific research, including journals, citation indexes, and research analytics.
- Intellectual Property: Offers intellectual property management, data, and analytics solutions for patents, trademarks, and domains.
- Life Sciences & Healthcare: Provides data, analytics, and insights to support drug development, commercialization, and healthcare decision-making.
Leadership and Structure
The leadership team includes Jonathan Gear as CEO. The company operates with a functional organizational structure across its business segments.
Top Products and Market Share
Key Offerings
- Web of Science: A leading citation database providing comprehensive coverage of scholarly literature. Competitors: Scopus (Elsevier), Google Scholar. Market Share estimates vary across specific research fields, but Web of Science is a dominant player.
- Derwent Innovation: A patent database offering enhanced patent information and analysis tools. Competitors: LexisNexis, Questel. Market Share in patent data and analytics is significant, with high revenue generation.
- Cortellis: A suite of life science intelligence solutions covering drug development. Competitors: IQVIA, Veeva Systems. Revenue from this product is significant and has many users.
Market Dynamics
Industry Overview
The market for research, intellectual property, and life sciences information is growing, driven by increasing R&D spending and the need for data-driven insights. Focus is shifting to AI-driven platforms.
Positioning
Clarivate is a key player in the industry, providing data, analytics, and workflow solutions. Its competitive advantage lies in its comprehensive data assets and trusted brands.
Total Addressable Market (TAM)
The TAM is estimated to be several billions of dollars annually, including research analytics, IP intelligence, and life science data. Clarivate is well-positioned to capture a significant share.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Comprehensive data assets
- Global presence
- Diverse product portfolio
- High renewal rates
Weaknesses
- High debt level
- Integration challenges from acquisitions
- Dependence on subscriptions
- Complexity of product offerings
- Potential exposure to open access initiatives
Opportunities
- Expanding into new geographic markets
- Developing new AI-powered products
- Acquiring complementary businesses
- Increasing penetration in existing markets
- Leveraging data analytics for new insights
Threats
- Competition from established players and new entrants
- Economic downturn affecting R&D spending
- Changing regulatory landscape
- Data privacy concerns
- Disruptive technologies
Competitors and Market Share
Key Competitors
- RELX (RELX)
- Wolters Kluwer (WOLK)
- IQVIA (IQV)
Competitive Landscape
Clarivate competes on data quality, product functionality, and customer service. RELX is a larger competitor with a broader portfolio, while IQVIA focuses on the life sciences market. Wolters Kluwer offers information and software solutions for professionals.
Major Acquisitions
ProQuest
- Year: 2021
- Acquisition Price (USD millions): 5300
- Strategic Rationale: Expanded Clarivate's content offerings and strengthened its position in the academic research market.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by acquisitions and organic revenue growth in key segments.
Future Projections: Analyst projections vary, but generally anticipate continued growth driven by demand for data and analytics.
Recent Initiatives: Recent initiatives include new product launches and strategic acquisitions to expand its product portfolio.
Summary
Clarivate is a significant player in the research and IP information space, benefiting from strong brands and comprehensive data. While it has a high debt load from acquisitions, it's positioned for growth through innovation and expansion into new markets. Competition and economic conditions pose ongoing challenges.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q)
- Industry reports
- Analyst estimates
- Press releases
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share figures are estimates and may vary. Actual results may differ from projections.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com | ||
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.